Helix BioMedix, Inc. (HXBM)
OTCMKTS · Delayed Price · Currency is USD
1.750
0.00 (0.00%)
At close: Aug 14, 2026
Helix BioMedix Market Cap
Helix BioMedix has a market cap or net worth of $393.24 thousand as of August 19, 2026. Its market cap has decreased by -56.25% in one year.
Market Cap
393.24K
Enterprise Value
n/a
Revenue
2.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.75
ChartMarket Cap Chart
Since July 26, 1995, Helix BioMedix's market cap has decreased from 1.59M to 393.24K, a decrease of -75.34%. That is a compound annual growth rate of -4.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 393.24K | -12.50% |
| Dec 31, 2025 | 449.42K | -75.00% |
| Dec 26, 2024 | 1.80M | -76.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Protagenic Therapeutics | 651.68K |
| Burzynski Research Institute | 591.52K |
| Halberd | 560.48K |
| THC Farmaceuticals | 505.87K |
| inTerra Resources | 443.23K |
| Mosaic ImmunoEngineering | 441.77K |
| Lyra Therapeutics | 425.97K |
| Altamira Therapeutics | 400.08K |